| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
disease | 0.100 | None | 1.000 | 6 | 221 | 2007 | 2014 | |||||||||
|
major histocompatibility complex, class II, DR beta 9 (pseudogene) | 0.682 | 0.654 |
|
disease | 0.100 | None | 1.000 | 5 | 21 | 2007 | 2019 | |||||||||
|
MSH5-SAPCD1 readthrough (NMD candidate) | 0.760 | 0.423 |
|
disease | 0.100 | None | 1.000 | 3 | 10 | 2007 | 2011 | |||||||||
|
ATP6V1G2-DDX39B readthrough (NMD candidate) | 0.769 | 0.423 |
|
disease | 0.100 | None | 1.000 | 3 | 8 | 2007 | 2011 | |||||||||
|
PPT2-EGFL8 readthrough (NMD candidate) | 0.792 | 0.462 |
|
disease | 0.100 | None | 1.000 | 3 | 6 | 2007 | 2011 | |||||||||
|
C2 antisense RNA 1 | 0.821 | 0.192 |
|
disease | 0.100 | None | 1.000 | 3 | 5 | 2007 | 2011 | |||||||||
|
EHMT2 and SLC44A4 antisense RNA 1 | 0.780 | 0.462 |
|
disease | 0.100 | None | 1.000 | 3 | 4 | 2007 | 2011 | |||||||||
|
major histocompatibility complex, class I, S (pseudogene) | 0.931 | 0.192 |
|
disease | 0.100 | None | 1.000 | 3 | 1 | 2007 | 2011 | |||||||||
|
collagen type XI alpha 2 pseudogene 1 | 0.805 | 0.462 |
|
disease | 0.100 | None | 1.000 | 3 | 5 | 2007 | 2011 | |||||||||
|
major histocompatibility complex, class II, DP alpha 2 (pseudogene) | 0.780 | 0.538 |
|
disease | 0.100 | None | 1.000 | 3 | 7 | 2007 | 2011 | |||||||||
|
thymopoietin pseudogene 1 | 1.000 | 0.115 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2007 | 2009 | |||||||||
|
HLA complex group 9 | 0.700 | 0.500 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2007 | 2009 | |||||||||
|
long intergenic non-protein coding RNA 2571 | 0.743 | 0.500 |
|
disease | 0.100 | None | 1.000 | 2 | 9 | 2007 | 2011 | |||||||||
|
HLA complex P5 | 0.595 | 0.808 |
|
disease | 0.100 | None | 1.000 | 2 | 5 | 2007 | 2009 | |||||||||
|
downregulated RNA in cancer, inhibitor of cell invasion and migration | 0.736 | 0.423 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2012 | 2019 | |||||||||
|
HLA complex group 22 (gene/pseudogene) | 0.736 | 0.423 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2007 | 2009 | |||||||||
|
long intergenic non-protein coding RNA 2649 | 0.792 | 0.308 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2012 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 243 | 0.729 | 0.423 |
|
disease | 0.100 | None | 1.000 | 2 | 6 | 2007 | 2009 | |||||||||
|
DDR1 divergent transcript | 0.931 | 0.115 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2007 | 2009 | |||||||||
|
HLA complex group 18 | 0.722 | 0.538 |
|
disease | 0.100 | None | 1.000 | 2 | 4 | 2007 | 2009 | |||||||||
|
HLA complex group 17 | 0.769 | 0.346 |
|
disease | 0.100 | None | 1.000 | 2 | 6 | 2007 | 2009 | |||||||||
|
zinc ribbon domain containing 1 antisense, pseudogene | 0.691 | 0.538 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2007 | 2009 | |||||||||
|
zinc finger DHHC-type containing 20 pseudogene 2 | 0.890 | 0.192 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | |||||||||
|
heterogeneous nuclear ribonucleoprotein A1 pseudogene 2 | 1.000 | 0.115 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | |||||||||
|
non-POU domain containing, octamer-binding pseudogene 2 | 0.861 | 0.231 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 |